Pyrazoloacridine in Treating Women With Refractory Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: pyrazoloacridine
Sponsor: Ohio State University Comprehensive Cancer Center
Collaborators: National Cancer Institute (NCI)